Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

IMPORTANCE: Most patients with atrial fibrillation (AF) and coronary artery disease have indications for preventing stroke with oral anticoagulation therapy and preventing myocardial infarction and stent thrombosis with platelet inhibition. OBJECTIVE: To evaluate whether the recently developed ABC (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Autores principales: Hijazi, Ziad, Oldgren, Jonas, Lindbäck, Johan, Alexander, John H., Alings, Marco, De Caterina, Raffaele, Eikelboom, John W., Ezekowitz, Michael D., Held, Claes, Huber, Kurt, Hylek, Elaine M., Granger, Christopher B., Lopes, Renato D., Vinereanu, Dragos, Siegbahn, Agneta, Wallentin, Lars
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495236/
https://ncbi.nlm.nih.gov/pubmed/32936298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.15943
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares